HepLOGIC Pilot and Feasibility Study
The HepLOGIC Pilot and Feasibility Study is being led by the Doherty Institue and Royal Melbourne Hospital in partnership with the Eastern Melbourne, South Eastern Melbourne and Gippsland Primary Health Networks, and Outcome Health.
The study aims to test a set of electronic tools that are integrated with the POLAR data environment and clinical software to support GPs to delivering guideline-based care to people living with chronic viral hepatitis and reduce their risk of liver cancer.
The pilot and feasibility study is one component of the Victorian Cancer Agency-funded project Hepatitis and liver cancer outcomes in general practice: an intervention collaboration (HepLOGIC).
This page provides resources to support primary care practices that are participating in the HepLOGIC Pilot and Feasibility Study.
Jump to:
> Using Walrus in the HepLOGIC study - for clinicians using Best Practice clinical software
> Using Walrus in the HepLOGIC study - for clinicians using Medical Director clinical software
> Clinical guidelines for hepatitis B and hepatitis C
For clinicians using Walrus with Best Practice software
Quick reference guide - using Walrus in the HepLOGIC study
(pdf download)
Watch video: Management of chronic viral hepatitis in primary care for liver cancer prevention
(approx 20 minutes, includes clinical guidance and Best Practice/Walrus walkthrough)
National guidance on testing and management is summarised in the following ashm quick reference guides:
For clinicians using Walrus with Medical Director software
Quick reference guide - using Walrus in the HepLOGIC study
(pdf download)
Watch video: Management of chronic viral hepatitis in primary care for liver cancer prevention
(approx 20 minutes, includes clinical guidance and Medical Director/Walrus walkthrough)
National guidance on testing and management is summarised in the following ashm quick reference guides:
Clinical guidelines for hepatitis B and hepatitis C
Patient ethnicity data collectionÂ
Aboriginal and Torres Strait Islander people and people born in high prevalence regions are at increased risk of hepatitis B and hepatitis C. The HepLOGIC study uses patient ethnicity as an indicator of risk, as this is a field most commonly available in practice software. Comprehensive data collection for patient ethnicity is therefore important to identifying people who should be tested for hepatitis B and hepatitis C.
Asking patients about their ethnicity or whether they are of Aboriginal or Torres Strait Islander descent can be difficult. The following videos aim to provide healthcare workers and practice staff with some guidance on how to ask the question.
Quick Reference Guide - Asking clients about ethnicity and country of birth
(pdf download)
Watch video: Asking clients about ethnicity and country of birth
(produced by project partner LiverWELL, approx 5 minutes, opens in new window)
Watch video: Ask the Question! (are you of Aboriginal or Torres Strait Islander descent?)
(produced by project partner Gippsland PHN, approx 4 minutes, opens in new window)
POLAR Walrus setup and use
Download quick reference guide: installing Walrus, adding users and user management
(pdf, produced by Eastern Melbourne PHN)
Watch video: Walrus setup and use
(produced by Eastern Melbourne PHN, opens in new window)
Download Walrus Troubleshooting guide for common issues and tips
(pdf)